MedPath

En Chu Kong Hospital

🇨🇳China
Ownership
Private
Established
1990-01-01
Employees
-
Market Cap
-
Website
http://www.eck.org.tw

Clinical Trials

8

Active:1
Completed:4

Trial Phases

3 Phases

Early Phase 1:1
Phase 2:2
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (40.0%)
Phase 2
2 (40.0%)
Early Phase 1
1 (20.0%)

Herbal Ointment in Treating Atopic Dermatitis Topically

Phase 2
Recruiting
Conditions
Atopic Dermatitis
Atopic Dermatitis (AD)
Atopic Dermatitis (Eczema)
Atopic Dermatitis Eczema
TCM
Skin Diseases
Skin Diseases, Genetic
Skin Diseases, Eczematous
Interventions
Drug: herbal ointment
Drug: Placebo
First Posted Date
2025-02-27
Last Posted Date
2025-02-27
Lead Sponsor
En Chu Kong Hospital
Target Recruit Count
66
Registration Number
NCT06850311
Locations
🇨🇳

En Chu Kong hospital, New Taipei City, Taiwan

The Changes of Urine Growth Factors Level

Early Phase 1
Completed
Conditions
Benign Prostatic Hyperplasia
Interventions
First Posted Date
2024-02-28
Last Posted Date
2024-02-28
Lead Sponsor
En Chu Kong Hospital
Target Recruit Count
74
Registration Number
NCT06282731
Locations
🇨🇳

En Chu Kong Hospital, New Taipei City, Taiwan

Mobile-assisted Case Management for Panic Disorder

Completed
Conditions
Panic Disorder
First Posted Date
2023-04-27
Last Posted Date
2024-03-01
Lead Sponsor
En Chu Kong Hospital
Target Recruit Count
159
Registration Number
NCT05832905
Locations
🇨🇳

En Chu Kong Hospital, Sanxia, New Taipei City, Taiwan

Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture

Not Applicable
Recruiting
Conditions
Hydronephrosis
Ureteral Stent Occlusion
Ureteral Stenosis
First Posted Date
2022-07-13
Last Posted Date
2022-07-13
Lead Sponsor
En Chu Kong Hospital
Target Recruit Count
200
Registration Number
NCT05455307
Locations
🇨🇳

En Chu Kong Hospital, New Taipei City, Taiwan

Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout Patients

Active, not recruiting
Conditions
Renal Impairment
Gout
Colchicine Adverse Reaction
Nonsteroidals (NSAIDs)Toxicity
Interventions
First Posted Date
2021-08-16
Last Posted Date
2021-08-16
Lead Sponsor
En Chu Kong Hospital
Target Recruit Count
2000
Registration Number
NCT05006001
  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath